Hydronidone capsules (F351)

· Shanghai Genomics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hydronidone capsules (F351), covering 2022-06-23 to 2022-06-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis [Phase 2]

See pricing